Marc Bijl

11.3k citations

154 papers · 6.7k indexed · h-index 49

Impact in

Rheumatology top 0.1%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Immunology top 0.5%
- T-cell and B-cell Immunology
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction

Papers in

Rheumatology 99
- Systemic Lupus Erythematosus Research 90
Immunology 93
- Atherosclerosis and Cardiovascular Diseases 28
- T-cell and B-cell Immunology 27
- Immune Cell Function and Interaction 15

Co-authors: Cees G. M. Kallenberg Johanna Westra Pieter C. Limburg Sander van Assen C. G. M. Kallenberg P. C. Limburg Karina de Leeuw Gerda Horst
Journals: Annals of the Rheumatic Diseases (18 papers)Lupus (13 papers)Arthritis Research & Therapy (11 papers)Autoimmunity Reviews (10 papers)Lara D. Veeken (9 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Marc Bijl

154 papers receiving 6.6k citations

Peers

Countries citing papers authored by Marc Bijl

Since Specialization

Citations

This map shows the geographic impact of Marc Bijl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Bijl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Bijl more than expected).

Fields of papers citing papers by Marc Bijl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Bijl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Bijl. The network helps show where Marc Bijl may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Bijl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Bijl Line = papers co-authored together Marc Bijl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts Lara D. Veeken ·Helen L. Leavis, Paul Van Daele, Catharina M. Mulders‐Manders, 美穂荻野, Abraham Rutgers, G. Elizabeth Legger, Marc Bijl, 修丽, Georgia Künecke, Femke Bonte‐Mineur, Cátia Meneguzi, Anna Simon, Pieter van Paassen, Marlies C. van der Goes, Marcel Flendrie, Joana Cardoso Vieira, Antoine W.T. van Lieshout, Gabriel Magnin, Sebastiaan J. Vastert, Sander W. Tas	2023	16
2	Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study Research and Practice in Thrombosis and Haemostasis ·Renate Ell, X. Fernandez, Andrés F. Prada-Caicedo, Paul Van Daele, Maria RP Gascón, Alexandre E. Voskuyl, Maarten Limper, Robbert J Goekoop, 胡锡骥, V. A. Shmukler, Marc Bijl, Xiuxuan Sun, Huali Yang, Hein J. Bernelot Moens, Karina de Leeuw, Karina Meijer	2022	7
3	EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021 Annals of the Rheumatic Diseases ·Marc H.A. Jansen, Christien Rondaan, G. Elizabeth Legger, Kirsten Minden, Yosef Uziel, Nataša Toplak, Despoina Maritsi, A. Réchou, Guy A. M. Berbers, Mariangela Genna, Weixun Qin, Vincenzo Tosello, Marc Bijl, Helen Foster, Isabelle Koné‐Paut, Carine Wouters, Angelo Ravelli, Ori Elkayam, Masters Kw, Marloes W Heijstek	2022	38
4	Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice Molecular Medicine ·Sezgin KOÇYİĞİT, Mirjan M. van Timmeren, Arjen H. Petersen, Gerda Horst, Marc Bijl, Pieter C. Limburg, Johanna Westra, Peter Heeringa	2016	16
5	Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective PubMed ·Robert W. Johnson, Eilberg Rg, Marc Bijl, Elisabetta Franco, J. Gaillat, J. Gorjão Clara, Marc Labétoulle, Jean‐Pierre Michel, Luigi Naldi, L. Salleras Sanmartí, Thomas Weinke	2015	176
6	Emerging role of high mobility group box 1 in ANCA-associated vasculitis Autoimmunity Reviews ·Chen Wang, Alexandre Wagner Silva de Souza, Johanna Westra, Marc Bijl, Min Chen, Ming‐Hui Zhao, Cees G. M. Kallenberg	2015	23
7	Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients? Lara D. Veeken ·Mas Roro Diah Wahyu Lestari, Gabriela Staniaszek, Johanna Westra, Andries J. Smit, Cees G. M. Kallenberg, Marcel D. Posthumus, Marc Bijl	2015	24
8	Lupus erythematosus revisited Seminars in Immunopathology ·Annegret Kuhn, Joerg Wenzel, Marc Bijl	2015	42
9	Folate Receptor-β Imaging Using ^99mTc-Folate to Explore Distribution of Polarized Macrophage Populations in Human Atherosclerotic Plaque Journal of Nuclear Medicine ·Gabriela Staniaszek, Johanna Westra, Reza Golestani, Gooitzen M. van Dam, Philip S. Low, René A. Tio, Riemer H. J. A. Slart, Hendrikus H. Boersma, Marc Bijl, Clark J. Zeebregts	2014	51
10	Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. PubMed ·Bernard Janov, Alexandre E. Voskuyl, Marc Vervloet, Marc Bijl, Ruud G.L. de Sévaux, Stefan P. Berger, R. H. W. M. Derksen, Jo H. M. Berden	2012	18
11	HMGB1 Is An Important Mediator in Cutaneous Inflammation in Systemic Lupus Erythematosus (SLE) Data Archiving and Networked Services (DANS) ·Jacques Dubucs, Johanna Westra, Gerda Horst, Pieter C. Limburg, Cees G. M. Kallenberg, Marc Bijl	2011	1
12	EULAR recommendations for vaccination in paediatric patients with rheumatic diseases Annals of the Rheumatic Diseases ·Marloes W Heijstek, Lisa M. Ott de Bruin, Marc Bijl, Ray Borrow, Fiona van der Klis, Isabelle Koné‐Paut, Anders Fasth, Kirsten Minden, Angelo Ravelli, Mario Abinun, Gecilmara Salviato Pileggi, Michael Borte, Nico Wulffraat	2011	152
13	Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature Journal of Cardiothoracic Surgery ·Wobbe Bouma, Theo J. Klinkenberg, Iwan CC van der Horst, Inez J. Wijdh‐den Hamer, Michiel E. Erasmus, Marc Bijl, Albert J.H. Suurmeijer, Felix Zijlstra, Massimo A. Mariani	2010	53
14	Treatment of lupus nephritis Expert Review of Clinical Immunology ·Sebastian Dolff, Jo H. M. Berden, Marc Bijl	2010	9
15	Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial Annals of the Rheumatic Diseases ·A Hartkamp, Rinie Geenen, G. L. R. Godaert, Marc Bijl, J. W. J. Bijlsma, R. H. W. M. Derksen	2009	35
16	Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcγ receptor–dependent mechanism Arthritis & Rheumatism ·Esther Reefman, Gerda Horst, J. S. Webster, Pieter C. Limburg, Cees G. M. Kallenberg, Marc Bijl	2007	41
17	Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients Annals of the Rheumatic Diseases ·Esther Reefman, Hilde Kuiper, P. C. Limburg, C. G. M. Kallenberg, Marc Bijl	2007	58
18	Role of the Fcγ receptor IIA polymorphism in the antiphospholipid syndrome: An international meta‐analysis Arthritis & Rheumatism ·Fotini B. Karassa, Marc Bijl, Kevin Davies, Cees G. M. Kallenberg, Munther A. Khamashta, Karin Manger, Marc Michel, Jean‐Charles Piette, Jane E. Salmon, Yeong Wook Song, Naoyuki Tsuchiya, Dae‐Hyun Yoo, John P. A. Ioannidis	2003	35
19	New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis The Netherlands Journal of Medicine ·Marc Bijl	2001	39
20	Do Elevated Levels of Serum-Soluble Fas Contribute to the Persistence of Activated Lymphocytes in Systemic Lupus Erythematosus? Journal of Autoimmunity ·Marc Bijl, Monica Koel Östbye, P. C. Limburg, PE Spronk, Sonja M.H.J. Jaegers, L Aarden, R J Smeenk, Augustin-Prosper Hacquard	1998	26

About Marc Bijl

Marc Bijl is a scholar working on Rheumatology, Immunology, Clinical Biochemistry, Nephrology and Hematology, having authored 154 papers that have together received 6.7k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (90 papers), Atherosclerosis and Cardiovascular Diseases (28 papers), T-cell and B-cell Immunology (27 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Vasculitis and related conditions (16 papers), Immune Cell Function and Interaction (15 papers), Advanced Glycation End Products research (15 papers) and Renal Diseases and Glomerulopathies (13 papers). The work is most often cited by research in Rheumatology (3.4k citations), Immunology (3.4k citations), Clinical Biochemistry (506 citations), Nephrology (516 citations) and Hematology (674 citations). Marc Bijl has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Cees G. M. Kallenberg, Johanna Westra, Pieter C. Limburg, Sander van Assen, C. G. M. Kallenberg, P. C. Limburg, Karina de Leeuw, Gerda Horst, Sebastian Dolff and Andries J. Smit. Their work appears in journals such as Annals of the Rheumatic Diseases, Lupus, Arthritis Research & Therapy, Autoimmunity Reviews and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact